NYU developing HIV antibodies and RNA test in a single POC

NYU team partners with Rheonix, Inc. on NIH grant to help achieve a commercial-ready test for use in the developing world New York University College of Dentistry has received a sub-award in the amount of $335,000 from a Small Business Innovation Research Phase II grant from the National Institutes of Health to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA from the AIDS virus in a single specimen. The $1.5M Phase II grant was awarded to Rheonix, Inc., an Ithaca, New York-based medical technology company, specializing in making automated and highly customizable molecular diagnostic devices.

http://ift.tt/1HZL5Km